1-7 of 7
Annette Schreiber, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adverse Events (AE) Under Imatinib Treatment Over 10 Years: Results From 1501 Patients Of The Randomized CML-Study IV

Rüdiger Hehlmann, MD, Michael Lauseker, Annette Schreiber, MD, Ulrike Proetel, MD, Lida Kalmanti, MD, Andreas Hochhaus, MD, Martin C. Müller, MD, Alice Fabarius, PhD, Stefan W. Krause, MD, Hermann Einsele, MD, Jolanta Dengler, MD, Christiane Falge, MD, Gabriela M. Baerlocher, MD, Lothar Kanz, Andreas Neubauer, MD, Michael Kneba, MD, Frank Stegelmann, MD, Michael Pfreundschuh, Prof MD, Cornelius F. Waller, MD, Karsten Spiekermann, PhD, Markus Pfirrmann, PhD, Susanne Saussele, MD, Joerg Hasford, MD
Journal: Blood
Blood (2013) 122 (21): 4012.
https://doi.org/10.1182/blood.V122.21.4012.4012
Published: 2013
Journal Articles

The Pattern Of Cytogenetic Aberrations In CML BC Stratified For Treatment

Christian Dietz, PhD, Lida Kalmanti, MD, Michael Lauseker, Claudia Haferlach, MD, Gudrun Göhring, MD, Brigitte Schlegelberger, MD, PhD, Martine Jotterand, MD, Barbara Heinze, MD, Dieter K. Hossfeld, MD, Rüdiger Hehlmann, MD, Andreas Hochhaus, MD, Martin C. Müller, MD, Benjamin Hanfstein, MD, Ulrike Proetel, MD, Annette Schreiber, MD, Stefan W. Krause, MD, Andreas Neubauer, MD, Cornelius F. Waller, MD, Markus Pfirrmann, PhD, Joerg Hasford, MD, Wolf-Karsten Hofmann, MD, Hans-Jochem Kolb, MD, Hermann Heimpel, MD, Susanne Saussele, MD, Alice Fabarius, PhD
Journal: Blood
Blood (2013) 122 (21): 2737.
https://doi.org/10.1182/blood.V122.21.2737.2737
Published: 2013
Journal Articles

Comorbidity, Measured By The Charlson Index, Has No Negative Impact On Remission In Patients With Chronic Myeloid Leukemia: Results Of The Randomized CML-Study IV

Susanne Saussele, MD, Marie Paloma Krauss, Michael Lauseker, Rüdiger Hehlmann, MD, Ulrike Proetel, MD, Annette Schreiber, MD, Lida Kalmanti, MD, Benjamin Hanfstein, MD, Hermann Einsele, MD, Christiane Falge, MD, Lothar Kanz, MD, Andreas Neubauer, MD, Michael Kneba, MD, Frank Stegelmann, MD, Michael Pfreundschuh, MD, Cornelius F. Waller, MD, Gabriela M. Baerlocher, MD, Dominik Heim, MD, Stefan W. Krause, MD, Wolf Karsten Hofmann, MD, Joerg Hasford, MD, Andreas Hochhaus, MD, Markus Pfirrmann, PhD, Martin C. Müller, MD
Journal: Blood
Blood (2013) 122 (21): 91.
https://doi.org/10.1182/blood.V122.21.91.91
Published: 2013
Journal Articles

Elderly CML Patients On Early Applied High Dose Imatinib Achieve Molecular Remissions As Fast As Younger Patients In Contrast To Patients On Standard Dose Imatinib: A Subanalysis Of The German CML-Study IV

Ulrike Proetel, MD, Nadine Pletsch, MD, Michael Lauseker, Lida Kalmanti, MD, Annette Schreiber, MD, Martin C. Müller, MD, Benjamin Hanfstein, MD, Stefan W. Krause, MD, Dominik Heim, MD, Gabriela M. Baerlocher, MD, Wolf-Karsten Hofmann, MD, Elisabeth Lange, MD, Hermann Einsele, MD, Martin Wernli, MD, Stephan Kremers, MD, Rudolf Schlag, MD, Lothar Müller, MD, Matthias Hänel, MD, Hartmut Link, MD, Bernd Hertenstein, MD, Markus Pfirrmann, PhD, Andreas Hochhaus, MD, Joerg Hasford, MD, Rüdiger Hehlmann, MD, Susanne Saussele, MD
Journal: Blood
Blood (2013) 122 (21): 96.
https://doi.org/10.1182/blood.V122.21.96.96
Published: 2013
Journal Articles

Secondary Malignancies in CML Patients – Data From the German CML Study IV

Manuel Barreto Miranda, MD, Michael Lauseker, Ulrike Proetel, MD, Annette Schreiber, MD, Benjamin Hanfstein, MD, Gabriela M. Baerlocher, MD, Dominik Heim, MD, Gerhard Ehninger, Dieter K. Hossfeld, MD, Hans-Jochem Kolb, MD, Stefan W. Krause, MD, Christoph Nerl, MD, Hermann Einsele, Mathias Hänel, MD, Jolanta Dengler, MD, Christiane Falge, MD, Lothar Kanz, MD, Andreas Neubauer, MD, Michael Kneba, MD, PhD, Frank Stegelmann, MD, Michael Pfreundschuh, MD, Cornelius F. Waller, MD, Karsten Spiekermann, MD, Wolf-Karsten Hofmann, Martin C. Müller, MD, Markus Pfirrmann, Andreas Hochhaus, MD, Joerg Hasford, Rüdiger Hehlmann, MD, Susanne Saussele, MD
Journal: Blood
Blood (2012) 120 (21): 3746.
https://doi.org/10.1182/blood.V120.21.3746.3746
Published: 2012
Journal Articles

Complete Molecular Remission (CMR 4.5) of CML Is Induced Faster by Dose – Optimized Imatinib and Predicts Better Survival - Results From the Randomized CML-Study IV

Rüdiger Hehlmann, MD, Michael Lauseker, Benjamin Hanfstein, MD, Martin C. Müller, MD, Annette Schreiber, MD, Ulrike Proetel, MD, Markus Pfirrmann, Claudia Haferlach, MD, Susanne Schnittger, PhD, Hermann Einsele, Jolanta Dengler, MD, Christiane Falge, MD, Lothar Kanz, MD, Andreas Neubauer, MD, Michael Kneba, MD, PhD, Frank Stegelmann, MD, Michael Pfreundschuh, MD, Cornelius F. Waller, MD, Karsten Spiekermann, MD, Gabriela M. Baerlocher, MD, Gerhard Ehninger, Dominik Heim, MD, Hermann Heimpel, Christoph Nerl, MD, Stefan W. Krause, Dieter K. Hossfeld, MD, Hans-Jochem Kolb, MD, Andreas Hochhaus, MD, Joerg Hasford, Susanne Saussele, MD
Journal: Blood
Blood (2012) 120 (21): 67.
https://doi.org/10.1182/blood.V120.21.67.67
Published: 2012
Journal Articles

Second Line Therapy with Second Generation TKI After Intolerance to Imatinib Based Treatments Showed High Overall Survival in Contrast to Second Line Therapy After Resistance; Results of the Randomized CML Study IV

Susanne Saussele, MD, Michael Lauseker, Ulrike Proetel, MD, Martin C. Müller, MD, Benjamin Hanfstein, MD, Annette Schreiber, MD, Florian Nolte, MD, Gabriela M. Baerlocher, MD, Gerhard Ehninger, MD, Dominik Heim, MD, Dieter K. Hossfeld, MD, PhD, Stefan W. Krause, MD, Christoph Nerl, MD, Hans Pralle, MD, Joerg E. A. Schubert, MD, Hermann Einsele, MD, Matthias Hänel, MD, Anthony D. Ho, MD, PhD, Christiane Falge, MD, Lothar Kanz, MD, Andreas Neubauer, MD, Michael Kneba, MD, Frank Stegelmann, MD, Michael Pfreundschuh, MD, Cornelius F. Waller, MD, Karsten Spiekermann, MD, Wolf Karsten Hofmann, MD, PhD, Jörg Hasford, MD, Markus Pfirrmann, PhD, Andreas Hochhaus, MD, Rüdiger Hehlmann, MD, for The SAKK, for The German CML Study Group
Journal: Blood
Blood (2011) 118 (21): 781.
https://doi.org/10.1182/blood.V118.21.781.781
Published: 2011